- Home
- PBYI vs OEC Comparison
PBYI vs OEC Comparison
Compare PBYI & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- OEC
- Stock Information
- Founded
- PBYI 2010
- OEC 1862
- Country
- PBYI United States
- OEC Luxembourg
- Employees
- PBYI N/A
- OEC N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- OEC Major Chemicals
- Sector
- PBYI Health Care
- OEC Industrials
- Exchange
- PBYI Nasdaq
- OEC Nasdaq
- Market Cap
- PBYI 263.4M
- OEC 297.6M
- IPO Year
- PBYI N/A
- OEC 2014
- Fundamental
- Price
- PBYI $4.95
- OEC $4.50
- Analyst Decision
- PBYI Strong Buy
- OEC Sell
- Analyst Count
- PBYI 1
- OEC 3
- Target Price
- PBYI $7.00
- OEC $8.33
- AVG Volume (30 Days)
- PBYI 418.9K
- OEC 933.2K
- Earning Date
- PBYI 11-06-2025
- OEC 11-04-2025
- Dividend Yield
- PBYI N/A
- OEC 1.84%
- EPS Growth
- PBYI 434.29
- OEC N/A
- EPS
- PBYI 0.97
- OEC N/A
- Revenue
- PBYI $238,062,000.00
- OEC $1,829,200,000.00
- Revenue This Year
- PBYI N/A
- OEC N/A
- Revenue Next Year
- PBYI N/A
- OEC $2.51
- P/E Ratio
- PBYI $5.08
- OEC N/A
- Revenue Growth
- PBYI 8.63
- OEC N/A
- 52 Week Low
- PBYI $2.32
- OEC $4.46
- 52 Week High
- PBYI $6.07
- OEC $19.48
- Technical
- Relative Strength Index (RSI)
- PBYI 45.94
- OEC 18.34
- Support Level
- PBYI $5.14
- OEC $5.12
- Resistance Level
- PBYI $5.52
- OEC $5.35
- Average True Range (ATR)
- PBYI 0.25
- OEC 0.31
- MACD
- PBYI -0.06
- OEC 0.01
- Stochastic Oscillator
- PBYI 17.82
- OEC 2.55
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About OEC Orion S.A.
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.